Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder
NCT03787628Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- May 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in opioid use disorder (OUD), sponsored by University of California, Los Angeles. Started May 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03787628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787628.